BAY CITY CAPITAL LLC

CIK 1288452 · last filed 2021-10-26

BAY CITY CAPITAL LLC is a corporate insider who has filed 23 SEC Form 4 insider transactions across 12 companies since 2007. The most recent filing, for XLO, was dated Oct 26, 2021. Across all open-market trades the lifetime net is −$489.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $93.3M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$93.34M

Companies

12

Total Filings

23

Lifetime Open-Market Net

-$489.64M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
XLO 10%+ Owner 816,990 $8.31 $6.79M $5.00M 1 2021-10-26
MDGL Director 154,255 $480.77 $74.16M -$586.74M 3 2020-05-29
IMRA 10%+ Owner 703,380 $17.02 $11.97M $0 1 2020-03-16
Kezar Life Sciences, Inc. (KZR) Delisted 10%+ Owner 622,229 $7.29 $4.54M $2.25M 1 2018-06-28
Viracta Therapeutics, Inc. (SNSS) Delisted 10%+ Owner 10,548,881 $18.62 $196.42M -$2.34M 4 2015-07-28
NEVRO CORP (NVRO) Delisted 42,658 $5.84 $249.1K $0 1 2014-11-12
DERM Director 65,572 $6.34 $415.7K $4.42M 1 2014-10-08
HYPERION THERAPEUTICS INC (HPTX) Delisted 10%+ Owner 2,221,067 $0 3 2013-07-19
Epizyme, Inc. (EPZM) Delisted 10%+ Owner 3,492,063 $1.47 $5.13M $10.00M 1 2013-06-07
ReShape Weightloss Inc. (ETRM) Delisted 10%+ Owner 51,451 $11.83M 3 2010-12-16
VIA Pharmaceuticals, Inc. (VIAP) Delisted 10%+ Owner 219,284 $39.52M 2 2007-08-08
PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted 10%+ Owner 4,383,684 $26.42M 1 2007-04-30

Recent Filings

23 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-10-26 XLO Mixed +1,129,490 $5.00M EDGAR
2020-05-29 MDGL Other (J) −1,648,944 $0 EDGAR
2020-03-16 IMRA Mixed +2,813,520 $0 EDGAR
2019-12-13 MDGL Sell (S) −4,800,000 -$506.26M EDGAR
2018-06-28 Kezar Life Sciences, Inc. (KZR) Delisted Mixed +622,229 $2.25M EDGAR
2018-06-12 MDGL Sell (S) −280,000 -$80.49M EDGAR
2016-08-02 Buy (P) +120,724,344 $12.00M
2015-07-28 Viracta Therapeutics, Inc. (SNSS) Delisted Mixed +4,120,512 -$2.5K EDGAR
2014-11-12 NEVRO CORP (NVRO) Delisted Conv (C) +8,773,028 $0 EDGAR
2014-10-08 DERM Mixed +13,957,628 $4.42M EDGAR
Showing 110 of 23
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.